Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.1400 (-3.42%) ($14.1400 - $14.1400) on Tue. Apr. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.88% (three month average) | RSI | 30 | Latest Price | $14.1400(-3.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) ARKK(44%) IBB(44%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.44% in a week (0% probabilities). VIXM(-35%) VXX(-26%) IGOV(-16%) UNG(-11%) TLT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.44% (StdDev 2.88%) | Hourly BBV | -2.4 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $15.31 | 5 Day Moving Average | $14.48(-2.35%) | 10 Day Moving Average | $14.48(-2.35%) | 20 Day Moving Average | $15.31(-7.64%) | To recent high | -31.7% | To recent low | 1.1% | Market Cap | $1.051b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |